Back to Search
DONALD FINDLAY, DO
DO
Emergency Medicine Physician
NPI: 1114912581Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma.
PMID 19276263·Clin Cancer Res·2009
7-preclinical
The generation of osteoclasts from RAW 264.7 precursors in defined, serum-free conditions.
PMID 19057837·J Bone Miner Metab·2009
7-preclinical
Gene expression profile of the bone microenvironment in human fragility fracture bone.
PMID 18840552·Bone·2009
8-other
The induction of a catabolic phenotype in human primary osteoblasts and osteocytes by polyethylene particles.
PMID 19349075·Biomaterials·2009
7-preclinical
Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synovium.
PMID 19171073·Arthritis Res Ther·2009
8-other
Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model.
PMID 19401351·Clin Cancer Res·2009
7-preclinical
Vitamin K promotes mineralization, osteoblast-to-osteocyte transition, and an anticatabolic phenotype by {gamma}-carboxylation-dependent and -independent mechanisms.
PMID 19675304·Am J Physiol Cell Physiol·2009
8-other
Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response.
PMID 18763010·Osteoporos Int·2009
8-other
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.
PMID 19630974·Trials·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 JEFFERSON AVE SE
GRAND RAPIDS, MI 49503 - Phone
- (800) 968-6866
Quick Facts
- NPI
- 1114912581
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile